These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 28976547)
1. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor. Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547 [TBL] [Abstract][Full Text] [Related]
2. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease. Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267 [TBL] [Abstract][Full Text] [Related]
3. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage. Ferrera D; Mazzaro N; Canale C; Gasparini L Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120 [TBL] [Abstract][Full Text] [Related]
4. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease. Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062 [TBL] [Abstract][Full Text] [Related]
5. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease. Lee MC; Yu WC; Shih YH; Chen CY; Guo ZH; Huang SJ; Chan JCC; Chen YR Sci Rep; 2018 Mar; 8(1):4772. PubMed ID: 29555950 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y; Qian Z; Wei G Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578 [TBL] [Abstract][Full Text] [Related]
7. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure. Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556 [TBL] [Abstract][Full Text] [Related]
9. α-synuclein-assisted oligomerization of β-amyloid (1-42). Chau E; Kim JR Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853 [TBL] [Abstract][Full Text] [Related]
10. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity? Saraiva AM; Pereira MC; Brezesinski G Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050 [TBL] [Abstract][Full Text] [Related]
11. Engineering of a peptide probe for β-amyloid aggregates. Aoraha E; Candreva J; Kim JR Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444 [TBL] [Abstract][Full Text] [Related]
12. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease. Murakami K Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729 [TBL] [Abstract][Full Text] [Related]
13. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity. Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344 [TBL] [Abstract][Full Text] [Related]
14. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699 [TBL] [Abstract][Full Text] [Related]
16. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease. Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423 [TBL] [Abstract][Full Text] [Related]
17. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils. Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region. Murakami K; Suzuki T; Hanaki M; Monobe Y; Akagi K; Irie K Biochem Biophys Res Commun; 2015 Oct; 466(3):463-7. PubMed ID: 26367176 [TBL] [Abstract][Full Text] [Related]
19. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878 [TBL] [Abstract][Full Text] [Related]
20. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]